stella
beta
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis — Stella
Home
/
EGF-R Positive Non-Small Cell Lung Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to EGF-R Positive Non-Small Cell Lung Cancer trials
Trial locations
(1 site)
China
Tangdu Hopspital, Xi’an, Shanxi